Patents by Inventor André Galarneau

André Galarneau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7955832
    Abstract: The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.
    Type: Grant
    Filed: December 3, 2004
    Date of Patent: June 7, 2011
    Assignee: ODYSSEY THERA Inc.
    Inventors: Stephen William Watson Michnick, André Galarneau
  • Publication number: 20050233348
    Abstract: The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.
    Type: Application
    Filed: December 3, 2004
    Publication date: October 20, 2005
    Applicant: Odyssey Thera, Inc.
    Inventors: Stephen William Michnick, Andre Galarneau
  • Patent number: 6828099
    Abstract: The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.
    Type: Grant
    Filed: May 31, 2001
    Date of Patent: December 7, 2004
    Assignee: Odyssey Thera Inc.
    Inventors: Stephen William Watson Michnick, André Galarneau
  • Publication number: 20030108869
    Abstract: The present invention describes an assay method comprising: (A) generating (1) at least a first fragment of a reporter molecule linked to a first interacting domain and at least a second fragment of a reporter molecule linked to a second interacting domain, or (2) nucleic acid molecules that code for (A)(1) and subsequently allowing said nucleic acid molecules to produce their coded products; then, (B) allowing interaction of said domains; and (C) detecting reconstituted reporter molecule activity, where said reporter molecule can react with a penicillin- or a cephalosporin-class substrate.
    Type: Application
    Filed: May 31, 2001
    Publication date: June 12, 2003
    Inventors: Stephen William Watson Michnick, Andre Galarneau